Strategic Advisors

Jason Aryeh

Strategic Advisor

Mr Jason Aryeh is a life sciences investment fund manager and pharmaceutical industry expert with over twenty years of equity investment experience in the life sciences sector.

Eric S. Fain, M.D.

Strategic Advisor

Dr. Eric S. Fain, M.D. is the former Senior Vice President and Group President, Cardiovascular and Neuromodulation at Abbott following its acquisition of St. Jude Medical.

John R. Barr

Strategic Advisor

Mr. John R. Barr has spent his career in medical devices. From October 2014 until August 2017, Mr. Barr has served as CEO at Surgical Specialties Inc., a privately held medical device firm specializing in wound closure and surgical knives that was sold to an investor group in March 2017.

Eric A. Rose, M.D.

Strategic Advisor

Dr. Eric Rose is a world-renowned innovative surgeon and scientist, best known for making history in 1984 when he performed the landmark achievement of the first successful pediatric heart transplant.

Gary Pruden

Strategic Advisor

Mr. Gary Pruden is a proven industry leader with a broad background in technology and pharmaceutical innovation and M&A transactions.

David Pacitti

Strategic Advisor

David Pacitti is President of Siemens Medical Solutions, Inc. and Head of Siemens Healthineers North America.

Louis Shapiro

Strategic Advisor

Mr. Louis Shapiro is President and CEO of Hospital for Special Surgery (“HSS”). He has served in this role since October 2006, overseeing all strategic and operational aspects of HSS and fulfilling its mission to advance the field of musculoskeletal medicine through world-class patient care, research and education.

Have any questions?
Contact us at 917.254.4900 or info@orchestrabiomed.com